Hämatologie Tumor Zentrum Aargau

Assessment and treatment

Diseases of the blood, lymphatic system, and bone marrow

Diseases affecting the blood, lymphatic system, or bone marrow are referred to as blood disorders or hematological disorders. They can affect the number or function of blood cells, as well as components of the clotting or immune system.

Hematology at the Tumor Zentrum Aargau focuses on the diagnosis and treatment of both benign and malignant diseases of the hematopoietic system.

Broad spectrum of diseases

What can you expect in hematology?

Hematology covers a broad spectrum of diseases. This includes benign disorders of the blood and blood-forming bone marrow as well as malignant “liquid” tumors.

Most common malignant hematological diseases

  • Leukemias

  • Lymphomas

  • Myelomas

  • Myelodysplastic syndromes

Benign hematological diseases

  • Anemia

  • Low platelet count

  • Low white blood cell count

  • Increased red or white blood cell count

  • Increased platelet count

  • Coagulation disorders

  • Thromboses

  • Iron storage diseases

Hematological diagnostics

Close collaboration with local laboratories and national reference centers

Hematological diagnostics are largely based on microscopic, clinical chemistry, molecular genetic, and immunological methods. Blood samples as well as tissue samples from the bone marrow or lymph nodes are examined.

From A to Z

Process of assessment and treatment

  • Consultation and initial assessment
    After referral, a timely hematology consultation takes place. All available findings are reviewed and—if necessary—further examinations are initiated.

  • Treatment concept
    Our goal is to develop an individualized treatment concept within a few working days. This is discussed in detail during the consultation and, if needed, explored further in an additional nursing consultation. The treatment plan and treatment goals are discussed together with patients and their relatives.

  • Diagnostics
    Hematological diagnostics are based on microscopic, clinical chemistry, molecular genetic, and immunological methods. Blood samples and—if required—tissue samples from the bone marrow or lymph nodes are examined. Diagnostics at Tumor Zentrum Aargau are carried out in close collaboration with local laboratories and national reference centers.

  • Outpatient treatment
    Many benign and also numerous malignant hematological diseases can be assessed and treated on an outpatient basis.

  • Inpatient or specialized therapies
    If inpatient treatment is necessary, it is provided in a specialized oncology ward. For certain complex therapies, for example for acute leukemias, high-dose therapies, or CAR T-cell therapies, referral to specialized centers is arranged if required.

In the event of changes in the blood count or symptoms

When is a hematological assessment indicated?

A hematological assessment is indicated if changes in the blood count are detected or symptoms suggest a disease of the blood-forming system.

This may be the case with:

  • Unexplained anemia

  • Abnormal blood values

  • Increased bleeding

  • Recurrent thromboses

  • Susceptibility to infections

  • Swollen lymph nodes

  • Unexplained general symptoms

Further assessment and treatment planning within hematology also take place in cases of suspected malignant diseases such as leukemias, lymphomas, or myelomas.